Navigation Links
Gulf oil dispersants unlikely to be endocrine disruptors and have relatively low cell toxicity
Date:7/21/2010

Government scientists are reporting that eight of the most commonly used oil dispersants used to fight oil spills, such as the massive episode in the Gulf of Mexico, appear unlikely to act as endocrine disruptors hormone-like substances that can interfere with reproduction, development, and other biological processes. The tested dispersants also had a relatively low potential for cytotoxicity (cell death), with JD-2000 and SAF-RON GOLD showing the least potential. The scientists are with the U. S. Environmental Protection Agency and the National Institutes of Health Chemical Genomics Center. Their findings appear in ACS' semi-monthly journal Environmental Science & Technology.

Richard Judson and colleagues note that more than 1.5 million gallons of dispersants have been used so far in the Deepwater Horizon spill. These detergent-like chemicals break up oil slicks into small drops. Scientists are concerned that some dispersants contain ingredients that turn into endocrine disruptors in the environment, and could harm marine mammals, fish, and humans. But only limited toxicity testing data is available on currently-used dispersants, and this is only results from the first round of EPA dispersant testing, they state.

With an urgent need for such information in the Deepwater Horizon spill, the scientists applied a rapid screening method using mammalian cells to determine the eight dispersants' potential to act as endocrine disruptors and relative toxicity to living cells. The dispersants included a type widely being used to treat the Gulf oil spill. None of the substances showed significant endocrine disruption activity and cytotoxicity was not seen until dispersants were tested at concentrations above 10 parts per million, the scientists said. However, they note that "there are other routes by which chemicals can cause endocrine disruption, as well as other types of toxicity that have not been tested for here."


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert  

Page: 1

Related biology news :

1. Global warming and other environmental dangers may be solved by unlikely source -- space technology
2. Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients
3. Scientific evidence of health problems from past contamination of drinking water at Camp Lejeune is limited and unlikely to be resolved with further study
4. Unlikely life thriving at Antarcticas Blood Falls
5. When it comes to sleep research, fruit flies and people make unlikely bedfellows
6. Scientists discover gene mutation responsible for hereditary neuroendocrine tumor
7. Comprehensive look at rare leukemia finds relatively few genetic changes launch disease
8. UR study reveals chemos toxicity to brain, possible treatment
9. Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer
10. A breath of fresh air could improve drug toxicity screening
11. Countries unite to reduce animal use in product toxicity testing worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gulf oil dispersants unlikely to be endocrine disruptors and have relatively low cell toxicity
(Date:8/19/2014)... study that analyzed concentrations of African dust transported ... winter and spring. These research findings offer new ... quality impacts of African dust, including the climate ... occur from increased African dust emissions in the ... (UM) Rosenstiel School of Marine and Atmospheric Science ...
(Date:8/19/2014)... This news release is available in French . ... Stand: balancing the BENEFITS and RISKS of physical activity ... a stand on the promotion of childhood physical activity ... Applied Physiology, Nutrition, and Metabolism ( APNM ... of knowledge in the area of risk of physical ...
(Date:8/19/2014)... , August 19, 2014 ... / Digital Wallet Choices as latest developments, ad campaigns ... Inc. (NASDAQ: EBAY ), Amazon.com Inc. (NASDAQ: ... AAPL ), Google Inc. (NASDAQ: GOOG ) ... (OTCQB: NXTD) a biometric authentication company focused on the ...
Breaking Biology News(10 mins):Study of African dust transport to South America reveals air quality impacts 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 3Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 2Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 3Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 4Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 5Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 6Digital Wallet Choices; PayPal, Google Wallet, Apple Passbook - and Now Wocket Smart Wallet : Who Addresses Issues of Security? 7
... discovered that very small chemical changes to dietary flavonoids cause ... for their impact on the human immune system., Plants are ... an average leaf for example, produces around 20,000. Many ... are already known to have medicinal properties with effects on ...
... and government, industry and health professionals will gather in ... the research supporting the health benefits of mushrooms ... produce aisle and often thought of as a vegetable ... The Mushrooms and Health Summit, held at the ...
... cholesterol levels and reducing the risks of cardiovascular disease, but ... The FASEB Journal suggests that they may extend ... which telomeres shorten, a key factor in the natural aging ... of statins, as an anti-aging therapy. "By telomerase activation, ...
Cached Biology News:Little changes -- large effects 2World's scientists, researchers and nutrition experts convene to explore the benefits of mushrooms 2
(Date:8/18/2014)... Sterne, Kessler, Goldstein & Fox P.L.L.C. , an intellectual ... , announced today that it has filed eleven petitions ... U.S. Patent and Trademark Office (USPTO) on behalf of ... BRLI).  These IPR petitions aim to nullify eleven patents ... patents have been asserted against GeneDx in patent infringement ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... rate of HIV infection and the number of deaths due ... positive rate across the globe. It has been estimated that ... 1.5 in 2013, with the rates for children being even ... the infection rates has been the improved access to antiretroviral ...
(Date:8/18/2014)... , August 18, 2014 ... Bioreactor Systems Market, By Application (Municipal Wastewater Treatment ... Flat Sheet and Multi Tubular), By Configuration (Internal/Submerged ... 2019", published by MarketsandMarkets, The market for membrane ... by 2019, growing at a CAGR of 15.28% ...
(Date:8/18/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: ... proprietary technologies are used to develop, manufacture and ... bio-based chemical, biopharmaceutical and industrial enzyme industries, announced ... on Form 10 with the U.S. Securities and ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The Form ...
Breaking Biology Technology:Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4
... ON , Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences ... financial results for the second quarter of fiscal 2010, ended ... numerous global in-licensing opportunities, we proposed to merge Cytopia Limited., ... during the second quarter," said David Allan , Chairman ...
... , DENVER and NEW ORLEANS , Feb. ... worldwide developer and marketer of diagnostic test kits, and Tulane ... to combat viral hemorrhagic fever (VHF), an effort that will generate ... the life of the contract. , The National Institutes of ...
... , Feb. 8 Neurocrine Biosciences, Inc. (Nasdaq: ... Ph.D. to its Board of Directors effective immediately. He is the ... Executive Chairman of Biogen Idec, Inc. , "We are very pleased ... said Joseph A. Mollica , Ph.D., Chairman of the Board ...
Cached Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2
... Tracker Intracellular Localization Kit provides a straight ... siRNA, of your design, in an efficient ... experiments. Subcellular localization and functional inhibition of ... introduction of the labeled siRNA into mammalian ...
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
... IT siRNA Tracker Intracellular Localization Kit provides ... and deliver siRNA, of your design, in ... vitro tracking experiments. Subcellular localization and functional ... monitored following introduction of the labeled siRNA ...
Biology Products: